Literature DB >> 28516310

Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas.

Linda M Pak1, Michael I D'Angelica1, Ronald P DeMatteo1, T Peter Kingham1, Vinod P Balachandran1, William R Jarnagin1, Peter J Allen2.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the outcome of patients presumed to have mucinous cysts of the pancreas who were initially selected for radiographic surveillance.
METHODS: Patients with a pancreatic cyst and a measured cyst fluid carcinoembryonic antigen (CEA) ≥192 ng/mL were included. Patients were stratified by those who underwent initial resection and those who were recommended for radiographic surveillance. The natural history of these two groups was examined.
RESULTS: From 1999 to 2014, 227 patients were identified who had a cyst fluid CEA ≥192 ng/mL (median 961, range 192-300,000 ng/mL). Immediate resection was performed on 63 patients (28%). Initial radiographic surveillance was recommended for 164 patients; 87% did not have main pancreatic duct dilation, and 87% met consensus criteria for radiographic surveillance. After a median follow-up of 56 months, 48 of the 164 patients (29%) had undergone resection. Ultimately, there were three cases (2%) of high-grade dysplasia and two cases of invasive carcinoma (1%) within these 164 patients selected for observation. Three of the five cases of either high-grade dysplasia or invasive carcinoma were among the 22 patients followed outside of consensus guidelines.
CONCLUSIONS: Appropriately selected patients with mucinous pancreatic cysts can be safely followed with serial surveillance with a low risk of malignant progression.

Entities:  

Keywords:  Intraductal papillary mucinous neoplasm; Mucinous cyst; Pancreatic cyst; Pancreatic cystic neoplasm

Mesh:

Substances:

Year:  2017        PMID: 28516310      PMCID: PMC5693653          DOI: 10.1007/s11605-016-3338-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas.

Authors:  Massimo Raimondo; Issei Tachibana; Raul Urrutia; Lawrence J Burgart; Eugene P DiMagno
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

2.  Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas.

Authors:  Satish Nagula; Timothy Kennedy; Mark A Schattner; Murray F Brennan; Hans Gerdes; Arnold J Markowitz; Laura Tang; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2010-07-24       Impact factor: 3.452

3.  Surgical treatment of intraductal papillary-mucinous tumors of the pancreas.

Authors:  N Kanazumi; A Nakao; T Kaneko; S Takeda; A Harada; S Inoue; T Nagasaka; N Nakashima
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

4.  Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts.

Authors:  Walter Gwang-Up Park; Ranjan Mascarenhas; Mario Palaez-Luna; Thomas C Smyrk; Dennis O'Kane; Jonathan E Clain; Michael J Levy; Randall K Pearson; Bret T Petersen; Mark D Topazian; Santhi S Vege; Suresh T Chari
Journal:  Pancreas       Date:  2011-01       Impact factor: 3.327

5.  Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms.

Authors:  Mee Joo Kang; Jin-Young Jang; Soo Jin Kim; Kyoung Bun Lee; Ji Kon Ryu; Yong-Tae Kim; Yong Bum Yoon; Sun-Whe Kim
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-17       Impact factor: 11.382

6.  Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts.

Authors:  Sevdenur Cizginer; Brian G Turner; Brian Turner; A Reyyan Bilge; Cetin Karaca; Martha B Pitman; William R Brugge
Journal:  Pancreas       Date:  2011-10       Impact factor: 3.327

7.  Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.

Authors:  William R Brugge; Kent Lewandrowski; Elizabeth Lee-Lewandrowski; Barbara A Centeno; Tara Szydlo; Susan Regan; Carlos Fernandez del Castillo; Andrew L Warshaw
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

8.  The incidental asymptomatic pancreatic lesion: nuisance or threat?

Authors:  Teviah Sachs; Wande B Pratt; Mark P Callery; Charles M Vollmer
Journal:  J Gastrointest Surg       Date:  2009-01-08       Impact factor: 3.452

9.  Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation.

Authors:  J Lafemina; N Katabi; D Klimstra; C Correa-Gallego; S Gaujoux; T P Kingham; R P Dematteo; Y Fong; M I D'Angelica; W R Jarnagin; R K Do; M F Brennan; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2012-10-31       Impact factor: 5.344

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  2 in total

1.  Pancreatic mucinous cystic neoplasms located in the distal pancreas: a multicenter study.

Authors:  Jose M Ramia; Juan Del Rio Martín; Gerardo Blanco-Fernández; Miguel Cantalejo-Diaz; Fernando Pardo; Elena Muñoz-Forner; Alberto Carabias; Alba Manuel-Vazquez; Pedro J Hernández-Rivera; Isabel Jaén-Torrejimeno; Helga K Kälviäinen-Mejia; Fernando Rotellar-Sastre; Marina Garcés-Albir; Raquel Latorre; Texell Longoria-Dubocq; Noelia De Armas-Conde; Alejandro Serrablo-Requejo; Sara Esteban Gordillo; Luis Sabater; Mario Serradilla-Martín
Journal:  Gland Surg       Date:  2022-05

2.  Large cystic lymphangioma of pancreas mimicking mucinous neoplasm: case report with a review of histological differential diagnosis.

Authors:  Mohammad Hossein Anbardar; Neda Soleimani; Arian Aminzadeh Vahedi; Seyed Ali Malek-Hosseini
Journal:  Int Med Case Rep J       Date:  2019-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.